Trending Health

The World Health Organization (WHO) has designated climate change the top risk to global healthcare. The relationship between climate change and human health is becoming increasingly pronounced as health systems and organisations are responding to public/private sustainability initiatives to mitigate climate risks while advancing the pursuit of health equity. In this episode, Mindy and Ryan are joined by Vynamic’s Ollie May to help us understand the NHS’s pledge to reach Net Zero emissions and how the healthcare industry can play a leading role in promoting greener business practices. The discussion begins with understanding the definition of Net Zero and how it is relevant to the healthcare industry (1:26). The conversation transitions to explaining the NHS’s carbon emission history and drivers impacting utilisation (3:27) before providing an overview of the system’s Net Zero commitment (6:50) and how waste factors into these plans (10:30). The team discusses the progress to-date since the NHS published their strategies (11:35) and the impact COVID-19 has had on their plans (15:49). The U.S. Net Zero practices are also discussed (19:05) before the team wraps up by weighing the benefits and challenges of these initiatives overall (21:45).

Podcast Tags: healthcare, healthcare news, Net Zero, Climate Change, NHS, COVID-19, health outcomes

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

List of Sources:

• https://www.england.nhs.uk/greenernhs/wp-content/uploads/sites/51/2022/07/B1728-delivering-a-net-zero-nhs-july-2022.pdf

Mindy McGrath, Healthcare Industry Advisor

[email protected]

Ryan Hummel, Executive and Head of Provider Sector

[email protected]

Oliver May, Director

[email protected]

In this episode, Jen, Mindy, and Ryan discuss recent newsworthy items, including the recent ruling by the United States Supreme Court on access to the abortion pill mifepristone, the declaration of bankruptcy by the Massachusetts-based Steward Health Care system, and the combination flu and COVID-19 vaccine under development by Moderna.

Podcast Tags: healthcare, healthcare news, life sciences, health policy, public health, Supreme Court, abortion, mifepristone, telemedicine, IVF, in vitro fertilization, private equity, hospitals, Steward Health Care, bankruptcy, COVID-19, flu, Moderna, mRNA, vaccines 

Source Links: 

• Supreme Court rejects challenge to abortion pill accessibility 
• The Threat to Abortion Rights You Haven’t Heard of 
• Senate Republicans block bill on women’s right to IVF as Democrats make push on reproductive care 
• Senate GOP Blocks IVF Access Bill as Democrats Press for Political Edge 
• Steward secures funding to run its hospitals through end of June 
• Unpacking Massachusetts’ Steward health system crisis 
• The 3rd Largest Mass Hospital system is in bankruptcy, here is what you need to know 
• Lawmakers seek healthcare and retirement protections for Steward Health Care Workers 
• Moderna flu/COVID combo beats immune responses for approved shots in phase 3 after speedy season 

Panel – Jen Burke, Mindy McGrath, Ryan Hummel 

Research & Production – Anna Briccetti, Jen Burke 

Recording & Editing – Mike Liberto, Rachel Skonecki 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC. 

In this episode, Jack and Jen welcome special guest Nico Renner, Patient Partnership Lead at Roche, to discuss the transformative impact of social media on patient engagement. Together they explore how pharmaceutical companies can embrace this shift to enhance patient interaction and outcomes.

Podcast Tags: healthcare, life sciences, patient engagement, patient centricity, patient outcomes, social media, metrics, innovation

Disclaimer: Nico is sharing his own opinions, which might not necessarily reflect Roche’s perspective

Check out Nico’s profile LinkedIn profile here: https://www.linkedin.com/in/nicorenner/ 

Source Links: 

• Harnessing the Power of Social Media in Pharmaceutical Marketing  
• Pharma and Healthcare Social Media Marketing Market 
• The Relationship Between the Pharmaceutical Industry and Social Media 
• Intelligent Post-launch Patient Support 
• Patient Education on Social Media is not the future… 

Panel – Jack Young, Nico Renner and Jen Burke

Research & Production – Jack Young, Nico Renner and Jen Burke

Recording & Editing –Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this episode, Jack, Jen, and Ollie discuss recent newsworthy items, including a roundup of key insights from the NEXT Pharma Summit, AstraZeneca’s announcements at ASCO, and the NHS’s groundbreaking trials for personalised cancer vaccines.

Podcast Tags: healthcare, healthcare news, NEXT Pharma Summit, life sciences, Novartis, generative AI, Lilly, omnichannel, AstraZeneca, Tagrisso, lung cancer, ASCO, NHS, vaccine 

Source Links: 

• Summit Therapeutics, AstraZeneca And More From The Year’s Biggest Cancer Conference 

• ASCO: AstraZeneca\’s Tagrisso, Imfinzi break new ground in lung cancer—with one standing ovation 

• ASCO24: AstraZeneca won cancer’s big meeting — again. Will that help it fulfill its $80 billion ambition? 

• ASCO Daily Recap: AstraZeneca’s hat trick, a GSK turnaround, and palliative care as telehealth 

• At ASCO, AstraZeneca Adds Data Supporting Expanded Use of Its Drugs in Lung Cancer 

• What To Know About Personalized mRNA Cancer Vaccines After Promising Trials From Moderna And Merck 

• Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up 

• Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up 

• ASCO: After Keytruda, Merck builds 3-pronged cancer strategy starring Moderna-partnered vaccine 

• Moderna And Merck Advance Cancer Treatment With Promising Vaccine 

• NHS patients in England to be offered trials for world-first cancer vaccine 

• Thousands of cancer patients to trial personalised vaccines 

Panel – Jack Young, Jen Burke, Ollie May 

Research & Production – Jack Young

Recording & Editing – Mike Liberto, Rachel Skonecki 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

As healthcare organizations strive to accelerate innovations through Artificial Intelligence (AI), it can be complicated to navigate through the number of possibilities that exist and know how to get started. In this episode, Jen is joined by Vynamic’s Tech & Digital Transformation Service Lead, Vince Annerhed-Harris and Lantern’s Chief Experience Officer, Brian Sturgeon, to discuss how healthcare leaders can plot the course for their AI journey and prioritize their investments to better accelerate their business objectives utilizing AI tools. 

Podcast Tags: health, healthcare, healthcare news, generative AI, innovation, responsible use, tech transformation, digital transformation  

Source Links: 

• The AI Strategy Roadmap: Navigating the stages of value creation | The Microsoft Cloud Blog 
• Introducing: Lantern – A Digital Innovation Consultancy Designed for the Era of AI (youtube.com) 
• A Practical Guide to Enabling AI within your Organization. (youtube.com)   
• Reimagining Technology Consulting for the Era of AI – Lantern (lanternstudios.com) 

Panel – Jen Burke, Vince Annerhed-Harris, Brian Sturgeon 

Research & Production – Everly Petruzzelli, Jen Burke 

Recording & Editing – Mike Liberto, Rachel Skonecki 

For more information on Lantern, please visit: Lantern – Microsoft Solutions Partner (lanternstudios.com), Lantern’s LinkedIn Page, Build and Modernize AI Apps – Microsoft Azure Marketplace 

If you want to learn more about implementing AI within your organization, you can check out Vynamic | Tech & Digital Transformation | Health Industry Consulting 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC. 

In this Trending News US episode, Jen, Mindy, and Ryan discuss recent newsworthy items, including legislation aimed at addressing drug shortages and telehealth regulations, the ongoing legal challenges to the Inflation Reduction Act, and the role of ride share apps in healthcare. 

Podcast Tags: healthcare, healthcare news, health policy, drug shortages, Medicare, hospitals, providers, FDA, telehealth, inflation reduction act, IRA, ride share, Lyft, Uber  

Source Links:

• Senators float Medicare program that would offer incentive payments to combat drug shortages   
• Second House panel advances two-year telehealth extension 
• Bristol Myers, Johnson & Johnson plot appeal after US judge dismisses IRA lawsuits 
• CMS proposes new mandatory organ transplant model for end-stage renal disease 

Panel – Jen Burke, Mindy McGrath, Ryan Hummel 

Research & Production – Anna Briccetti, Jen Burke 

Recording & Editing – Mike Liberto, Rachel Skonecki 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

During Fierce Life Science’s MASS East, Medical Affairs leaders gathered to address current challenges and share industry best practices. In this episode, Jen is joined by Vynamic’s Tamaron Bertelli and Head of Life Sciences Europe, Gemma Pfister to share what they learned about transformation and operating with impact.

To receive a copy of Vynamic\’s \”Operating with Impact: Topical Transformation Dilemmas and Decisions\” presentation, please email

For more information about Vynamic\’s work in Medical Affairs, please visit

Podcast Tags: healthcare, healthcare news, life sciences, medical affairs, MASS East, Fierce, MSL 

Panel – Gemma Pfister, Jen Burke, Tamaron Bertelli  

Research & Production – Jen Burke 

Recording & Editing – Mike Liberto, Rachel Skonecki 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC. 

In this Trending News Europe episode, Jack, Jen, and Ollie discuss a few recent newsworthy items, including an increase in cyberattacks on the healthcare sector, Europe’s plan to future-proof its Biotech Sector and New Research from the University of Oxford into psilocybin as a potential treatment for depression. 

Podcast Tags: healthcare, healthcare news, life sciences, NHS, cybersecurity, biotech, research & development, pharmaceuticals, depression, psilocybin, mental health, psychedelics, mental health awareness week 

Source Links: 

• \’Large volume\’ of data stolen from NHS Dumfries and Galloway published on dark web 

Panel – Jack Young, Jen Burke, Ollie May 

Research & Production – Jack Young 

Recording & Editing – Mike Liberto, Rachel Skonecki 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC. 

As competitive and regulatory pressures increase, Life Sciences organizations are tightening their timelines and budgets when bringing products to market. In this environment, it’s become essential to start commercialization planning earlier to ensure a successful launch and hit revenue targets. In this deep dive episode, Jen is joined by Vynamic’s Product Launch Service Leads, Ashley Stanley and Brian Stamm, as well as Managing Director of PROPENSITY4, Chris Savage, to discuss why early planning is so critical and how leaders can incorporate some of these changes into their organizations.  

To learn more about Vynamic’s work in Product Launch, visit Vynamic’s Product Launch page. To read more on navigating alliance product launches, see Vynamic’s latest insight here.  

PROPENSITY4, part of Inizio Engage, is transforming pharmaceutical commercialization through seamless integration of data, expertise and cutting-edge analytics. See more about what PROPENSITY4 can do for your team at Data and Integrated Insights | Inizio Engage.  

Podcast Tags: healthcare, life sciences, product launch, healthcare news, life sciences trends, product launch trends

Source Links:

• Product launch challenges and how to overcome them
• Drug launches reflect overall company performance
• TO SPEND OR NOT TO SPEND: Investing For Launch Success As An Emerging Company
• Revenue of the worldwide pharmaceutical market from 2001 to 2023
• Prices for new US drugs rose 35% in 2023, more than the previous year
• Next in pharma 2024: Reinventing for returns
• The Unbearable Cost of Drug Development
• Understanding the Factors that Impact the Pre-Launch Phase and New Product Launch Excellence in the Pharmaceutical Industry
• FDA Approves Many New Drugs in 2023 that Will Benefit Patients and Consumers

Panel – Jen Burke, Ashley Stanley, Chris Savage, Brian Stamm

Research & Production – Adrea Cope & Everly Petruzzelli

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this episode, Mindy, Ryan, and Jen discuss recent newsworthy items, including the FDA approval of Rejoyn, the first prescription digital treatment for major depressive disorder. They also discuss the ongoing drug shortage crisis, as well as changes coming out of the Centers for Medicare & Medicaid Services and the impact those decisions will have over the next year.  

Podcast Tags: healthcare, healthcare news, life sciences, health policy, public health, depression, mental health, digital treatment, drugs, pharmaceuticals, shortages, medications, FDA, CMS, Medicare Advantage, breakthrough technology, medical devices 

Source Links: 

• FDA clears first digital treatment for depression, but experts caution that research is still early 
• Number of ongoing US drug shortages reaches new high, pharmacist group says 
• FDA commissioner tells lawmakers his agency needs more authority to prevent drug shortages 
• CMS final rule on broker comp, health equity could shake up Medicare Advantage 
• Medicare official says breakthrough device reimbursement rule coming in early summer 

Panel – Jen Burke, Mindy McGrath, Ryan Hummel 

Research & Production – Anna Briccetti, Jen Burke 

Recording & Editing – Mike Liberto, Rachel Skonecki 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.